---
figid: PMC4959441__nihms-775218-f0001
figlink: /pmc/articles/PMC4959441/figure/F1/
number: F1
caption: RAS-mediated signal transduction pathways and post-translational modification
  of RAS. (A) The RAS-RAF-MEK-ERK is commonly implicated as the primary signaling
  pathway of RAS. Ligand activated RTKs in turn activate GEFs, which catalyze the
  formation of RAS-GDP, the inactive form, into RAS-GTP, the active form. RAS-GTP
  then acts on multiple downstream effectors, including PI3K and RAL pathways. (B)
  Post-translational modification of RAS C termini include multiple enzyme-catalyzed
  lipidation processes. Farnesylation (blue diamond) occurs on the Cys of the conserved
  CAAX region of the C termini. RAS then undergoes a proteolytic clearvage of AAX
  and carboxymethalation. The isoforms HRAS, NRAS, and KRas4A additionally undergo
  palmitoylation (orange diamond). PDEδ and Galactin escort RAS for its ultimate recruitment
  into the plasma membrane. * Indicates enzymes currently targeted in studies for
  RAS inhibition related to RAS trafficking.
pmcid: PMC4959441
papertitle: Therapeutic Approaches to RAS Mutation.
reftext: Aaron J Scott, et al. Cancer J. ;22(3):165-174.
pmc_ranked_result_index: '130385'
pathway_score: 0.9533616
filename: nihms-775218-f0001.jpg
figtitle: RAS-mediated signal transduction pathways and post-translational modification
  of RAS
year: ''
organisms:
- Homo sapiens
ndex: fd6661b1-deba-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4959441__nihms-775218-f0001.html
  '@type': Dataset
  description: RAS-mediated signal transduction pathways and post-translational modification
    of RAS. (A) The RAS-RAF-MEK-ERK is commonly implicated as the primary signaling
    pathway of RAS. Ligand activated RTKs in turn activate GEFs, which catalyze the
    formation of RAS-GDP, the inactive form, into RAS-GTP, the active form. RAS-GTP
    then acts on multiple downstream effectors, including PI3K and RAL pathways. (B)
    Post-translational modification of RAS C termini include multiple enzyme-catalyzed
    lipidation processes. Farnesylation (blue diamond) occurs on the Cys of the conserved
    CAAX region of the C termini. RAS then undergoes a proteolytic clearvage of AAX
    and carboxymethalation. The isoforms HRAS, NRAS, and KRas4A additionally undergo
    palmitoylation (orange diamond). PDEδ and Galactin escort RAS for its ultimate
    recruitment into the plasma membrane. * Indicates enzymes currently targeted in
    studies for RAS inhibition related to RAS trafficking.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - AKT2
  - AKT1
  - PIK3CA
  - MAPK1
  - ARAF
  - EGFR
  - SOS1
  - PIK3CB
  - MAP2K1
  - PIK3CG
  - MAP2K2
  - AKT3
  - PIK3CD
  - RAF1
  - MTOR
  - RASA1
  - PIK3R5
  - PIK3R4
  - PIK3R3
  - SLC2A4RG
  - HRAS
  - RALA
  - NRAS
  - MAPK3
  - BRAF
  - RCE1
  - KRAS
  - SOS2
  - RALGDS
  - PIK3R6
  - RALB
  - Cancer
  - Cardiomyopathy
  - Lung cancer
  - Noonan syndrome
genes:
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: ARAF
  entrez: '369'
- word: EGFR)
  symbol: EGFR
  source: hgnc_symbol
  hgnc_symbol: EGFR
  entrez: '1956'
- word: (Sos)
  symbol: SOS
  source: bioentities_symbol
  hgnc_symbol: SOS1
  entrez: '6654'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: MEK1/2
  symbol: MEK1
  source: hgnc_alias_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: MEK1/2
  symbol: MEK2
  source: hgnc_alias_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: MTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: GAP
  symbol: GAP
  source: hgnc_alias_symbol
  hgnc_symbol: RASA1
  entrez: '5921'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: ERK1/2
  symbol: ERK2
  source: hgnc_alias_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: GEF
  symbol: GEF
  source: hgnc_alias_symbol
  hgnc_symbol: SLC2A4RG
  entrez: '56731'
- word: HRAS,
  symbol: HRAS
  source: hgnc_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: RALA
  symbol: RALA
  source: hgnc_symbol
  hgnc_symbol: RALA
  entrez: '5898'
- word: NRAS,
  symbol: NRAS
  source: hgnc_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: RCE1
  symbol: RCE1
  source: hgnc_symbol
  hgnc_symbol: RCE1
  entrez: '9986'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: ERK1/2
  symbol: ERK1
  source: hgnc_alias_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: (Sos)
  symbol: SOS
  source: bioentities_symbol
  hgnc_symbol: SOS2
  entrez: '6655'
- word: RAL-GDS
  symbol: RALGDS
  source: hgnc_symbol
  hgnc_symbol: RALGDS
  entrez: '5900'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: RALB
  symbol: RALB
  source: hgnc_symbol
  hgnc_symbol: RALB
  entrez: '5899'
chemicals: []
diseases:
- word: Cancer
  source: ''
  identifier: ''
- word: Cardiomyopathy
  source: ''
  identifier: ''
- word: Lung cancer
  source: ''
  identifier: ''
- word: Noonan syndrome
  source: ''
  identifier: ''
figid_alias: PMC4959441__F1
redirect_from: /figures/PMC4959441__F1
figtype: Figure
---
